Which patients improve: Characteristics increasing sensitivity to a supportive patient-practitioner relationship

Social Science and Medicine

Volumn 70, Issue 3, 2010, Pages 479-484

  Conboy, Lisa Ann ^a   Macklin, Eric ^b   Kelley, John ^b   Kokkotou, Efi ^c   Lembo, Anthony ^c   Kaptchuk, Ted ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

False discovery rate analysis; Patient practitioner relationship; Randomized controlled trial; Social factors; USA

Indexed keywords

BIOINFORMATICS; GENOMICS; HEALTH SERVICES; HEALTH WORKER; QUALITY OF LIFE; SYMPTOM;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA COLLECTION METHOD; DOCTOR PATIENT RELATION; FEMALE; HUMAN; INTERVIEW; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT CARE; PERSONAL EXPERIENCE; PSYCHOSOCIAL CARE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SOCIAL ISOLATION; SOCIAL SUPPORT; SYMPTOMATOLOGY; TREATMENT OUTCOME;

FALSE POSITIVE REACTIONS; FEMALE; HUMANS; INTERVIEWS AS TOPIC; IRRITABLE BOWEL SYNDROME; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT-CENTERED CARE; PHYSICIAN-PATIENT RELATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOCIAL ISOLATION; SOCIAL SUPPORT;

BOSTON; MASSACHUSETTS; UNITED STATES;

EID: 73149109054     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.socscimed.2009.10.024     Document Type: Article

References (47)

1. Benjamini Y., and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Series B 57 (1995) 289-300
2. Berkman L., and Kawachi I. Social epidemiology (2000), Oxford University Press, New York
3. Camilleri M., Mayer E.A., Drossman D.A., Heath A., Dukes G.E., McSorley D., et al. Improvement in pain and Bowel function in female irritable Bowel patients with alosetron, a 5-HT3 receptor antagonist. Alimentary Pharmacology & Therapeutics 13 (1999) 1149-1159
4. Camilleri M., Northcutt A.R., Kong S., Dukes G.E., McSorley D., and Mangel A.W. Efficacy and safety of alosetron in women with irritable Bowel syndrome: a randomised, placebo-controlled trial. Lancet 355 (2000) 1035-1040
5. Carroll B.J., Feinberg M., Smouse P.E., Rawson S.G., and Greden J.F. The Carroll rating scale for depression. I. Development, reliability and validation. The British Journal of Psychiatry 138 (1981) 194-200
6. Cohen S. Social relationships and health. American Psychologist 59 (2004) 676-684
7. Cohen S., Doyle W.J., Skoner D.P., Rabin B.S., and Gwaltney J.M. Social ties and susceptibility to the common cold. JAMA 277 (1997) 1940-1944
8. Cohen S., Doyle W.J., Turner R.B., Alper C.M., and Skoner D.P. Childhood socioeconomic status and host resistance to infectious illness in adulthood. Psychosomatic Medicine 66 (2004) 553-558
9. Cohen S., and Hoberman H. Positive events and social supports as buffers of life change stress. Journal of Applied Social Psychology 13 (1983) 99-125
10. Cohen S., Kamarck T., and Mermelstein R. A global measure of perceived stress. Journal of Health and Social Behavior 24 (1983) 385-396
11. Cohen S., Mermelstein R., Kamarck T., and Hoberman H. Measuring the functional components of social support. In: Sarason I.G., and Sarason B.R. (Eds). Social support: Theory, research, and application (1985), Martinus Nijhoff, The Hague, Holland
12. Cohen S., and Williamson G. Perceived stress in a probability sample of the U.S. In: Spacapam S., and Oskamp S. (Eds). The social psychology of health: Claremont symposium on applied social psychology (1988), Sage, Newbury Park, CA
13. Conboy L., Wasserman R.H., Legedza A.T., Park M., Rivers A., Morey E.B., et al. Investigating placebo effects in irritable Bowel syndrome: a novel research design. Journal of Controlled Clinical Trials 27 (2006) 123-134
14. DiMatteo M.R., and DiNocola D.D. Achieving patient compliance (1982), Pergamon Press, New York
15. Drossman D.A., and Lembo A.J. Contemporary diagnosis and management of irritable Bowel syndrome (2002) Newtown, PA
16. Drossman D.A., Whitehead W.E., and Camilleri M. Irritable Bowel syndrome: a technical review for practice guideline development. Gastroenterology 112 (1997) 2120-2137
17. Drossman D., Morris C.B., Hu Y., Toner D.B., Diamant N., Whitehead W.E., et al. Characterization of health related quality of life (HRQOL) for patients with functional Bowel disorder (FBD) and its response to treatment. American Journal of Gastroenterology 102 (2007) 1-12
18. Efron B. Large-scale simultaneous hypothesis testing: the choice of a null hypothesis. Journal of the American Statistical Association 99 (2004) 96-104
19. Efron, B. (2006). Size, Power, and False Discovery Rates. http://www-stat.stanford.edu/∼ckirby/brad/papers/2006Size.pdf.
20. Efron B. Size, power and false discovery rates. Annals of Statistics 35 (2007) 1351-1377
21. Francis C.Y., Morris J., and Whorwell P.J. The irritable Bowel severity scoring system: a simple method of monitoring irritable Bowel syndrome and its progress. Alimentary & Pharmacological Therapy 11 (1997) 395-402
22. Gordon S., Ameen V., Bagby B., Shahan B., Jhingran P., and Carter E. Validation of irritable Bowel syndrome global improvement scale: an integrated symptom end point for assessing treatment efficacy. Digestive Diseases & Sciences 48 (2003) 1317-1323
23. Greenfield S., Kaplan S.H., Ware Jr. J.E., Yano E.M., and Frank H.J.L. Patient's participation in medical care: effects on blood sugar control and quality of life in diabetics. Journal of General Internal Medicine 3 (1988) 448-457
24. Heaven B.R., Murtagh M.J., Rapley T., May C.R., Graham R.H., Kaner E.F., et al. Patients or research subjects? A qualitative study of participation in a randomized controlled trial of a complex intervention. Patient Education and Counseling 62 2 (2006) 260-270
25. Kabacoff R.I., Sega D.L., Hersen M., and Van Hasselt V.B. Psychometric properties and diagnostic utility of the beck anxiety inventory and the state-trait anxiety inventory with older adult psychiatric outpatients. Journal of Anxiety Disorders 11 1 (1997) 33-47
26. Kaplan S.H., Greenfield S., and Ware Jr. J.E. Assessing the effects of physician-patient interactions on the outcomes of chronic disease. Medical Care 27 (1989) S110-S127
27. Kaptchuk T.J. Powerful placebo: the dark side of the randomized controlled trial. Lancet 351 (1998) 1722-1725
28. Kaptchuk T.J. The double-blind randomized controlled trial: gold standard or golden calf. Journal of Clinical Epidemiology 54 (2001) 541-549
29. Kaptchuk T.J., Kelley J.M., Conboy L.A., Kerr C.E., Jacobson E.E., et al. Components of placebo effect: randomized controlled trial in patients with irritable Bowel syndrome. BMJ 336 (2008) 999-1003
30. Kaptchuk T.J., Shaw J., Kerr C.E., Conboy L.A., Kelley J.M., Lembo A.J., et al. Maybe i made up the whole thing: placebos and patients' experiences in a randomized controlled trial. Culture Medicine & Psychiatry 33 (2009) 382-411
31. Kiecolt-Glaser J.K., Fisher L.D., Ogrocki P., Stout J.C., and Speicher C.E. Marital quality, marital disruption and immune function. Psychosomatic Medicine 49 (1987) 13-34
32. Lembo A.L., Wright R.A., Bagby B., Decker C., Gordon S., and Jhingran P. Alosetron controls Bowel urgency and provides global symptom improvement in women with diarrhea-predominant irritable Bowel syndrome. American Journal of Gastroenterology 96 (2001) 2662-2670
33. Lewis S., and Heaton K. Stool form scale as a useful guide to intestinal transit time. Scandinavian Journal of Gastroenterology 32 9 (1997) 920-924
34. Martin R., Barron J.J., and Zacker C. Irritable Bowel syndrome: toward a cost effective management approach. American Journal of Managed Care 7 Suppl. 8 (2001) S268-S275
35. Melzack R. The McGill pain questionnaire: major properties and scoring methods. Pain 1 (1975) 277-299
36. Miller G.E., Cohen S., and Ritchey K.A. Chronic psychological stress and the regulation of pro-inflammatory cytokines: a glucocorticoid-resistance model. Health Psychology 21 (2002) 531-541
37. Mitchell C.M., and Drossman D.A. Survey of the AGA membership relating to patients with functional gastrointestinal disorders. Gastroenterology 92 (1987) 1282-1284
38. Mumford E., Schlesinger H.J., and Glass G.V. The effects of psychological intervention on recovery from surgery and heart attacks: an analysis of the literature. American Journal of Public Health 72 (1982) 141-151
39. Murtagh M.J., Thomson R.G., May C.R., Rapley T., Heaven B.R., Graham R.G., et al. Qualitative methods in a randomised controlled trial: the role of an integrated qualitative process evaluation in providing evidence to discontinue the intervention in one arm of a trial of a decision support tool. Quality and Safety in Health Care 16 3 (2007) 224-229
40. Orth J.E., Stiles W.B., Scherwitz L., Hennrikus D., and Vallabone C. Patient exposition and provider explanation in routine interviews and hypertensive patients' blood pressure control. Health Psychology 6 1 (1987) 29-42
41. Piotrowski C. The status of the beck anxiety inventory in contemporary research. Psychological Reports 85 1 (1999) 261-262
42. Pressman S., Cohen S., Miller G.E., Barkin A., Rabin B.S., and Treanor J. Loneliness, social network size and immune response to influenza vaccination in college freshmen. Health Psychology 24 3 (2005) 297-306
43. Roter D.L., and Hall J.A. Doctors talking with patients: Patients talking with doctors (1992) Auburn House, CT
44. Sandler R.S., Everhart J.E., Donowitz M., Adams E., Cronin K., Goodman C., et al. The burden of selected digestive diseases in the United States. Gastroenterology 122 (2002) 1500-1511
45. Thomas P.D., Goodwin J.M., and Goodwin J.S. Effect of social support on stress-related changes in cholesterol levels, uric acid level and immune function in an elderly sample. American Journal of Psychiatry 142 (1985) 735-737
46. Uchino B.N., Cacciopo J.T., and Kiecolt-Glaser J.K. The relationship between social support and physiological processes: a review with emphasis on underlying mechanisms and implications for health. Psychological Bulletin 119 (1996) 488-531
47. Wright R.J., Cohen S., Wand M., and Gold D.R. Chronic caregiver stress and IgE expression, allergen-induced proliferation, and cytokine profiles in a birth cohort predisposed to atopy. Journal of Allergy & Clinical Immunology 113 (2004) 1051-1057